 |
Previous Article | Next Article 
The Journal of Neuroscience, September 1, 2002, 22(17):7650-7661
Neuronal Apoptosis Associated with Morphine Tolerance: Evidence
for an Opioid-Induced Neurotoxic Mechanism
Jianren
Mao1,
Backil
Sung1,
Ru-Rong
Ji2, and
Grewo
Lim1
1 Massachusetts General Hospital Pain Center and
2 Neural Plasticity Research Group, Department of
Anesthesia and Critical Care, Massachusetts General Hospital, Harvard
Medical School, Boston, Massachusetts 02114
Tolerance to the analgesic effect of an opioid is a pharmacological
phenomenon that occurs after its prolonged administration. Activation
of the NMDA receptor (NMDAR) has been implicated in the cellular
mechanisms of opioid tolerance. However, activation of NMDARs can lead
to neurotoxicity under many circumstances. Here we demonstrate that
spinal neuronal apoptosis was induced in rats made tolerant to morphine
administered through intrathecal boluses or continuous infusion. The
apoptotic cells were predominantly located in the superficial spinal
cord dorsal horn, and most apoptotic cells also expressed glutamic acid
decarboxylase, a key enzyme for the synthesis of the inhibitory
neurotransmitter GABA. Consistently, increased nociceptive sensitivity
to heat stimulation was observed in these same rats. Mechanistically,
the spinal glutamatergic activity modulated morphine-induced neuronal
apoptosis, because pharmacological perturbation of the spinal glutamate
transporter activity or coadministration of morphine with the NMDAR
antagonist (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d]
cyclohepten-5,10-imine maleate affected both morphine tolerance
and neuronal apoptosis. At the intracellular level, prolonged morphine
administration resulted in an upregulation of the proapoptotic
caspase-3 and Bax proteins but a downregulation of the antiapoptotic
Bcl-2 protein in the spinal cord dorsal horn. Furthermore,
coadministration with morphine of
N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (a pan-caspase inhibitor) or
acetyl-aspartyl-glutamyl-valyl-aspart-1-aldehyde (a relatively
selective caspase-3 inhibitor) blocked morphine-induced neuronal
apoptosis. Blockade of the spinal caspase-like activity also partially
prevented morphine tolerance and the associated increase in nociceptive
sensitivity. These results indicate an opioid-induced neurotoxic
consequence regulated by the NMDAR-caspase pathway, a mechanism that
may have clinical implications in opioid therapy and substance abuse.
Key words:
apoptosis; opioid tolerance; analgesia; NMDA; glutamate
transporter; caspase-3; Bax; Bcl-2
Copyright © 2002 Society for Neuroscience 0270-6474/02/22177650-12$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. Sandkuhler
Models and Mechanisms of Hyperalgesia and Allodynia
Physiol Rev,
April 1, 2009;
89(2):
707 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Yan Zhang, Qiuyue Chen, and L.-C. Yu
Morphine: A Protective or Destructive Role in Neurons?
Neuroscientist,
December 1, 2008;
14(6):
561 - 570.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, S. Wang, B. Sung, G. Lim, and J. Mao
Morphine Induces Ubiquitin-Proteasome Activity and Glutamate Transporter Degradation
J. Biol. Chem.,
August 1, 2008;
283(31):
21703 - 21713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-L. Svensson, N. Bucht, M. Hallberg, and F. Nyberg
From the Cover: Reversal of opiate-induced apoptosis by human recombinant growth hormone in murine foetus primary hippocampal neuronal cell cultures
PNAS,
May 20, 2008;
105(20):
7304 - 7308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
EAPC Abstracts
Palliative Medicine,
April 1, 2006;
20(3):
229 - 379.
[PDF]
|
 |
|

|
 |

|
 |
 
E. Polgar, D. I. Hughes, A. Z. Arham, and A. J. Todd
Loss of Neurons from Laminas I-III of the Spinal Dorsal Horn Is Not Required for Development of Tactile Allodynia in the Spared Nerve Injury Model of Neuropathic Pain
J. Neurosci.,
July 13, 2005;
25(28):
6658 - 6666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev.,
September 1, 2004;
56(3):
351 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Ballantyne and J. Mao
Opioid Therapy for Chronic Pain
N. Engl. J. Med.,
November 13, 2003;
349(20):
1943 - 1953.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tegeder, S. Grosch, A. Schmidtko, A. Haussler, H. Schmidt, E. Niederberger, K. Scholich, and G. Geisslinger
G Protein-independent G1 Cell Cycle Block and Apoptosis with Morphine in Adenocarcinoma Cells: Involvement of p53 Phosphorylation
Cancer Res.,
April 15, 2003;
63(8):
1846 - 1852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sung, G. Lim, and J. Mao
Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the Pathogenesis of Neuropathic Pain in Rats
J. Neurosci.,
April 1, 2003;
23(7):
2899 - 2910.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|